- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Cancer Epidemiology
Volume 2012 (2012), Article ID 706469, 6 pages
Impact of HIV Infection on Medicare Beneficiaries with Lung Cancer
Department of Biostatistics, University of Arkansas for Medical Sciences, 4301 West Markham, No. 781, Little Rock, AR 72205, USA
Received 19 October 2011; Revised 17 January 2012; Accepted 26 January 2012
Academic Editor: Jennifer Beebe-Dimmer
Copyright © 2012 Jeannette Y. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- E. A. Engels, R. J. Biggar, H. I. Hall et al., “Cancer risk in people infected with human immunodeficiency virus in the United States,” International Journal of Cancer, vol. 123, no. 1, pp. 187–194, 2008.
- M. S. Shiels, R. M. Pfeiffer, M. H. Gail et al., “Cancer burden in the HIV-infected population in the United States,” Journal of the National Cancer Institute, vol. 103, no. 9, pp. 753–762, 2011.
- P. Patel, D. L. Hanson, P. S. Sullivan et al., “Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003,” Annals of Internal Medicine, vol. 148, no. 10, pp. 728–736, 2008.
- L. Pantanowitz, H. P. Schlecht, and B. J. Dezube, “The growing problem of non-AIDS-defining malignancies in HIV,” Current Opinion in Oncology, vol. 18, no. 5, pp. 469–478, 2006.
- E. P. Simard, R. M. Pfeiffer, and E. A. Engels, “Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States,” Cancer, vol. 117, no. 5, pp. 1089–1096, 2011.
- M. S. Shiels, S. R. Cole, G. D. Kirk, and C. Poole, “A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 5, pp. 611–622, 2009.
- M. J. Silverberg, C. Chao, W. A. Leyden et al., “HIV infection and the risk of cancers with and without a known infectious cause,” AIDS, vol. 23, no. 17, pp. 2337–2345, 2009.
- N. A. Hessol, E. C. Seaberg, S. Preston-Martin et al., “Cancer risk among participants in the women's interagency HIV study,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 4, pp. 978–985, 2004.
- J. Reekie, C. Kosa, F. Engsig et al., “Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies,” Cancer, vol. 116, no. 22, pp. 5306–5315, 2010.
- M. J. Silverberg and D. I. Abrams, “Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?” Current Opinion in HIV and AIDS, vol. 4, no. 1, pp. 42–51, 2009.
- G. D'Jaen, L. Pantanowitz, M. Bower et al., “Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration,” Clinical Lung Cancer, vol. 11, no. 6, pp. 396–404, 2010.
- M. S. Shiels, R. M. Pfeiffer, and E. A. Engels, “Age at cancer diagnosis among persons with AIDS in the United States,” Annals of Internal Medicine, vol. 153, no. 7, pp. 452–460, 2010.
- T. Powles, C. Thirwell, T. Newsom-Davis et al., “Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?” British Journal of Cancer, vol. 89, no. 3, pp. 457–459, 2003.
- A. Lavolé, C. Chouaïd, L. Baudrin et al., “Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer,” Lung Cancer, vol. 65, no. 3, pp. 345–350, 2009.
- A. Makinson, J.-C. Tenon, S. Eymard-Duvernay et al., “Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study,” Journal of Thoracic Oncology, vol. 6, no. 6, pp. 1022–1029, 2011.
- O. Beahrs, D. Henson, R. Hutter, et al., AJCC Cancer Stating Manual, New York, NY, USA, J. B. Lippincott Company, 3rd edition, 1988.
- D. Spiegelman and E. Hertzmark, “Easy SAS calculations for risk or prevalence ratios and differences,” American Journal of Epidemiology, vol. 162, no. 3, pp. 199–200, 2005.
- D. E. Gilden, J. M. Kubisiak, and D. M. Gilden, “Managing Medicare's HIV caseload in the era of suppressive therapy,” American Journal of Public Health, vol. 97, no. 6, pp. 1053–1059, 2007.
- HIV/AIDS Surveillance Report, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Ga, USA, 2007.
- American Cancer Society, Cancer Facts & Figures 2011, Atlanta, Ga, USA, 2011.
- “HIV surveillance—United States, 1981–2008,” Morbidity and Mortality Weekly Report, vol. 60, no. 21, pp. 689–693, 2011.
- D. K. Owens, V. Sundaram, L. C. Lazzeroni et al., “Prevalence of HIV infection among inpatients and outpatients in department of veterans affairs health care systems: implications for screening programs for HIV,” American Journal of Public Health, vol. 97, no. 12, pp. 2173–2178, 2007.
- S. Lieb, J. Prejean, D. R. Thompson et al., “HIV prevalence rates among men who have sex with men in the southern united states: population-based estimates by race/ethnicity,” AIDS and Behavior, vol. 15, no. 3, pp. 596–606, 2011.
- F. Xu, M. R. Sternberg, and L. E. Markowitz, “Men who have sex with men in the united states: demographic and behavioral characteristics and prevalence of hiv and hsv-2 infection: results from national health and nutrition examination survey 2001–2006,” Sexually Transmitted Diseases, vol. 37, no. 6, pp. 399–405, 2010.
- HIV Surveillance in Urban and Nonurban Areas, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention, Division of HIV/AIDS Prevention, 2010, http://www.cdc.gov/hiv/topics/surveillance/resources/slides/urban-nonurban/index.htm.
- E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison, and R. D. Moore, “Elevated incidence of lung cancer among HIV-infected individuals,” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1383–1388, 2006.
- G. D. Kirk, C. Merlo, P. O'Driscoll et al., “HIV infection is associated with an increased risk for lung cancer, independent of smoking,” Clinical Infectious Diseases, vol. 45, no. 1, pp. 103–110, 2007.
- “Vital signs: current cigarette smoking among adults aged ≥18 years—United States, 2009,” Morbidity and Mortality Weekly Report, vol. 59, no. 35, pp. 1135–1140, 2010.
- A. R. Lifson, J. Neuhaus, J. R. Arribas, M. D. van Berg-Wolf, A. M. Labriola, and T. R. H. Read, “Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial,” American Journal of Public Health, vol. 100, no. 10, pp. 1896–1903, 2010.
- H. Pines, L. Koutsky, and S. Buskin, “Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996–2008),” AIDS and Behavior, vol. 15, no. 1, pp. 243–251, 2011.
- Centers for Disease Control and Prevention, National Center for Health Statistics, National Interview Survey, 2010, Family Core Component, 2011.
- HIV/AIDS Surveillance Report, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Ga, USA, 2008.
- H. I. Hall, R. Song, P. Rhodes et al., “Estimation of HIV incidence in the United States,” Journal of the American Medical Association, vol. 300, no. 5, pp. 520–529, 2008.
- S. Zou, K. A. Dorsey, E. P. Notari et al., “Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing,” Transfusion, vol. 50, no. 7, pp. 1495–1504, 2010.
- A. B. Nattinger, T. L. McAuliffe, and M. M. Schapira, “Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research,” Journal of Clinical Epidemiology, vol. 50, no. 8, pp. 939–945, 1997.